MXPA03002242A - Utilizacion de una hormona de liberacion (rh) para la preparacion de un medicamento para la prevencion de la degradacion del cartilago articular. - Google Patents

Utilizacion de una hormona de liberacion (rh) para la preparacion de un medicamento para la prevencion de la degradacion del cartilago articular.

Info

Publication number
MXPA03002242A
MXPA03002242A MXPA03002242A MXPA03002242A MXPA03002242A MX PA03002242 A MXPA03002242 A MX PA03002242A MX PA03002242 A MXPA03002242 A MX PA03002242A MX PA03002242 A MXPA03002242 A MX PA03002242A MX PA03002242 A MXPA03002242 A MX PA03002242A
Authority
MX
Mexico
Prior art keywords
rhein
articular cartilage
cartilage damage
medicine
preparing
Prior art date
Application number
MXPA03002242A
Other languages
English (en)
Inventor
Jean-Pierre Pelletier
Original Assignee
Negma Lerads
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Negma Lerads filed Critical Negma Lerads
Publication of MXPA03002242A publication Critical patent/MXPA03002242A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La invencion se relaciona al uso de la hormona de liberacion (RH) y derivados de la hormona de liberacion (RH) en terapia. La hormona de liberacion (RH) y derivados de la hormona de liberacion (RH) se utilizan en terapia humana y animal para prevenir y/o limitar el dano al cartilago articular, si se requiere en combinacion con una analgesico un antipiretico, un agente anti-inflamatorio no esferoidal o un inhibidor COX-¦¦. La invencion se aplica en terapia reumatoide.
MXPA03002242A 2000-09-15 2001-09-14 Utilizacion de una hormona de liberacion (rh) para la preparacion de un medicamento para la prevencion de la degradacion del cartilago articular. MXPA03002242A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/663,528 US6610750B1 (en) 2000-09-15 2000-09-15 Treatment of osteoarthritis
PCT/FR2001/002876 WO2002022119A1 (fr) 2000-09-15 2001-09-14 Utilisation d'une rhéine pour la préparation d'un médicament pour la prévention de la dégradation du cartilage articulaire

Publications (1)

Publication Number Publication Date
MXPA03002242A true MXPA03002242A (es) 2004-03-26

Family

ID=24662217

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA03002242A MXPA03002242A (es) 2000-09-15 2001-09-14 Utilizacion de una hormona de liberacion (rh) para la preparacion de un medicamento para la prevencion de la degradacion del cartilago articular.

Country Status (7)

Country Link
US (1) US6610750B1 (es)
EP (1) EP1317263A1 (es)
AU (1) AU2001290033A1 (es)
CA (1) CA2422093A1 (es)
IL (1) IL154917A0 (es)
MX (1) MXPA03002242A (es)
WO (1) WO2002022119A1 (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6927044B2 (en) * 1998-09-25 2005-08-09 Regeneron Pharmaceuticals, Inc. IL-1 receptor based cytokine traps
FR2842738B1 (fr) * 2002-07-23 2006-02-10 Negma Lerads Utilisation d'une rheine pour la preparation d'un medicament pour le traitement de l'inflammation chronique, la prevention et le traitement du rejet des transplantations d'organes et de tissus
US20040162582A1 (en) * 2003-02-13 2004-08-19 Hmt High Medical Technologies Ag Treatment of osteoarthritis
MXPA04009698A (es) * 2004-10-04 2006-04-05 Maria Elena Garcia Armenta Formulaciones farmaceuticas solidas conteniendo diacereina y meloxicam.
EP2060562A1 (en) 2007-11-16 2009-05-20 Laboratoire Medidom S.A. Dioxoanthracene sulphonate derivatives
BR112012013330A2 (pt) * 2009-12-02 2017-03-28 Acceleron Pharma Inc composições e métodos para aumentar meia vida do soro de proteínas de fusão fc
EP2718328A4 (en) 2011-06-08 2014-12-24 Acceleron Pharma Inc COMPOSITIONS AND METHODS FOR INCREASING THE HALF TIME OF SERUM
TWI461192B (zh) * 2011-07-20 2014-11-21 Twi Biotechnology Inc 降低血脂異常病患之糖化血色素的醫藥組成物
US20180311199A1 (en) * 2016-01-12 2018-11-01 Lawrence Chan Combination treatment for inflammatory diseases
TW201739448A (zh) * 2016-05-06 2017-11-16 安成生物科技股份有限公司 用於治療及/或預防血液相關疾病之方法及配方
CN110191710B (zh) * 2017-01-19 2023-04-18 安成生物科技股份有限公司 用于预防或治疗免疫炎性皮肤病的方法和药物组合物

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA761627B (en) * 1976-03-16 1978-01-25 C Friedmann Improvements in or relating to the treatment of arthritis
IT1244886B (it) * 1990-12-11 1994-09-13 Gentili Ist Spa Dicarbonati e uretani dell'acido 4,5-diidrossi- e 4,5,8-triidrossi- 9,10-diidro-9,10-diosso-2-antracencarbossilico ad azione terapeutica
GB9417102D0 (en) * 1994-08-24 1994-10-12 Lilly Industries Ltd Pharmaceutical compounds
IT1276781B1 (it) * 1995-06-23 1997-11-03 Gentili Ist Spa Derivati antrachinonmono- e disolfon- sostituiti e composizioni farmaceutiche che li contengono per il trattamento delle patologie
IT1283772B1 (it) * 1996-07-31 1998-04-30 Medidom Lab Procedimento per la preparazione di reina e diacereina

Also Published As

Publication number Publication date
US6610750B1 (en) 2003-08-26
WO2002022119A1 (fr) 2002-03-21
IL154917A0 (en) 2003-10-31
CA2422093A1 (fr) 2002-03-21
AU2001290033A1 (en) 2002-03-26
EP1317263A1 (fr) 2003-06-11

Similar Documents

Publication Publication Date Title
PL339342A1 (en) Synergetically acting analgesic combination of an opioidic antaligic drug and an inhibitor of cyclo-oxygenase-2
EE200100373A (et) Bensoheterotsüklid ja nende kasutamine MEK inhibiitoritena
MXPA03002242A (es) Utilizacion de una hormona de liberacion (rh) para la preparacion de un medicamento para la prevencion de la degradacion del cartilago articular.
BRPI0413363A (pt) formas de dosagem fornecendo liberação controlada de inibidores de proteìna de transferência de ésteres de colesterila e liberação imediata de inibidores de hmg-coa redutase
EP1177793A8 (fr) Aérosol médicamenteux inhalable dans le traitement ou la prévention de la douleur
ES2149264T3 (es) Agente terapeutico para el tratamiento de melanomas.
BR9915285A (pt) Composição farmacêutica para liberação modificada de um sensitivador de insulina e um outro agente antidiabético
SV2003000633A (es) Nuevos tiadiazoles y oxadiazoles y su uso como inhibidores de fosfodiesterasa-7
HK1049164A1 (zh) 吲衍生物和其在治療骨質疏鬆中的應用以及其它應用
DK1294372T3 (da) Törpulverformulering der omdanner racecadotril
TR199801511T2 (xx) Farmas�tik bile�im.
ATE478662T1 (de) Arzneilösungen enthaltend modafinilverbindungen
ES2163735T3 (es) Compuestos biarilos heterociclicos, composiciones farmaceuticas y cosmeticas que los contienen y utilizaciones.
BR0213181A (pt) Combinações de inibidor de cox-2
BR0112212A (pt) Uma combinação de inibidores de fbpase e agentes antidiabéticos úteis para o tratamento de diabetes
BR9915215A (pt) Composição farmacêutica para liberação modificada de sensibilizador de insulina
AU7862401A (en) Pharmaceutical compostion comprising trkaig2 for use in the prevention and/or treatment of cancer
CY1108053T1 (el) Ενωση της κυαμεμαζινης και ενος ατυπου νευροληπτικου
HUP0301348A3 (en) Analgesic and anti-inflammatory compositions containing gox-2 inhibitors and their use
DK1007052T3 (da) Kombinationer af endometrisk skånende progesteroner og endometrisk atrofiserende progesteroner med östrogener ved oral svangerskabs-forebyggelse
EE200200163A (et) Loteprednooli ja ß2-adrenoretseptori agonistide uued kombinatsioonid
TR200001075T2 (tr) Tiamfenikol ve diklofenak içeren bileşimler.
HU0001888D0 (en) 5ht1 receptor agonists and either cox-2 inhibitor or nsaid for the treatment of migraine
NO20071096L (no) Diarylmetylpiperazinderivater, fremstillinger derav og anvendelser derav
MX9603999A (es) Tratamiento de nefropatia diabetica con valsartan.

Legal Events

Date Code Title Description
FA Abandonment or withdrawal